Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Solana Company - Class A Common Stock (NQ:HSDT)

1.439 +0.059 (+4.30%)
Streaming Delayed Price Updated: 10:32 AM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Solana Company - Class A Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares climbed 91.2% to $10.81. 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Helius Medical Tech: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For Helius Medical Tech ↗
 
Via Benzinga
News headline image
Helius Medical Tech's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Earnings Preview For Helius Medical Tech ↗
 
Via Benzinga
News headline image
Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday. 
Via Benzinga
News headline image
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Looking Into Helius Medical Tech's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
MS, Stroke and mmTBI Cover Broader Set of Indications Across North American Markets 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards. 
Via InvestorPlace
News headline image
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning! 
Via InvestorPlace
News headline image
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.; HealthTech Connex Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
-- PoNS already approved in Canada for treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury (TBI) and gait deficit due to mild and moderate symptoms from Multiple... 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
Physical therapists in attendance can enhance their skillset with free on-site PoNS training 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
PTAP Lowers the Cost of PoNS Therapy™ for Qualified Americans 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
New Partnership with UpScript Provides Access to Care, Delivers PoNS Devices to Doorsteps 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.